Cell therapy of acute myocardial infarction: open questions.

Document Viewing Options:

• Detailed Record
• PDF Full Text

  Source: Cardiology

  Date: January 1, 2009

  Inside this work

  Full Text Contents

  • 74 Adenosine deaminase ...
  • 76 Cardiac sarcoidosis ...
  • 1 Pleiotropic effects ...
  • 4 Pleiotropic effects ...
  • 13 Myocardial bridging ...
  • 22 Role of the calpain ...
  • 31 Transcatheter closur...
  • 35 Long-term outcomes a...
  • 36 Mortality and resten...
  • 42 Tako-Tsubo-like card...
  • 49 Drug-eluting stents ...
  • 56 The relationship of ...
  • 60 Sleep apnea genetics...
  • 62 Endothelin-1 gene va...
  • 69 Latent development o...
  • 81 Atrial gap junctions...
  • 89 Experimental study o...
  • 98 Intracoronary delive...
  • 107 Long-term follow-up ...
  • 114 Development of funct...
  • 122 Transmural peak syst...
  • 129 Chronic erythropoiet...
  • 135 Diabetes mellitus an...
  • 138 Diabetes mellitus: i...
  • 144 Mortality and reinfa...
  • 151 Relation between AT1...
  • 165 QT dispersion: still...
  • 168 The comparative effe...
  • 174 Erectile dysfunction...
  • 158 Isolated left ventri...
  • 178 Autoantibodies in at...
  • 200 Myocardial involveme...
  • 188 Elevation of cardiac...
  • 180 Effects of autoantib...
  • 209 Noninvasive coronary...
  • 191 Moderate-severe rena...
  • 202 Patients with infect...
  • 205 Post-mortem analysis...
  • 211 Diagnostic capacity ...
  • 219 Effects of vitamins ...
  • 224 The human G147D-prot...
  • 232 Cardiac impact of lo...
  • 234 Long-term assessment...
  • 243 Ischemic mitral regu...
  • 244 Ischemic mitral regu...
  • 260 Restenosis and gene ...
  • 263 P27 and P53 gene pol...
  • 270 Treatment of stable ...
  • 279 Berberine-induced up...
  • 287 Prevalence and outco...
  • 294 Atenolol is inferior...
  • 303 The renin-angiotensi...
  • 1 Cardiac and extracar...
  • 9 Treatment of acute d...
  • 12 Impact of intravenou...
  • 20 Cryptogenic emboli i...
  • 25 The desmosome in the...
  • 28 Homozygous mutation ...
  • 35 The quest for the op...
  • 50 Presence and extent ...
  • 59 The effects of chira...
  • 66 Autonomic nervous fu...
  • 72 Clinical reinfarctio...
  • 81 MicroRNA: novel regu...
  • 89 Efficacy of ezetimib...
  • 98 The influence of ose...
  • 108 Closure of PFO: scie...
  • 111 Maximal potential pa...
  • 116 Left ventricular sys...
  • 122 Long-term prognostic...
  • 132 The association of a...
  • 138 Increased augmentati...
  • 146 An unusual cause of ...
  • 149 The effect of acute ...
  • 155 Cell therapy of acut...
  • 161 Differential express...
  • 169 The dynamics of QT d...
  • 172 Early reduction of Q...
  • 180 Variability of high-...
  • 184 Evaluation of right ...
  • 193 Plasma B-type natriu...
  • 198 Patterns of presenta...
  • 207 Troponin T concentra...
  • 213 Long-term (up to 18 ...
  • 222 The German Transregi...
  • 231 The Maya ball game. ...
  • 236 ACP1 genetic polymor...
  • 243 Role of Doppler echo...
  • 246 Mitral regurgitation...
  • 249 Pivotal role of beds...
  • 260 Percutaneous revascu...
  • 264 Distal left main cor...
  • 274 Serotonergic and sym...
  • 277 Disrupted serotonerg...
  • 287 Stunned myocardium f...
  • 291 Fibronectin gene exp...
  • 1 Atrial Na,K-ATPase i...
  • 8 Vascular endothelial...
  • 11 Association of VEGF ...
  • 19 What is the structur...
  • 22 Decreased connexin 4...
  • 30 The role of aldoster...
  • 32 Long-term low-dose s...
  • 39 'Death and life are ...
  • 42 The effects of intra...
  • 47 Neurocardiogenic syn...
  • 50 A novel method for t...
  • 56 Robot for coronary a...
  • 59 Quality of life impr...
  • 67 Sunitinib malate, a ...
  • 72 Prognostic stratific...
  • 75 Rapid clinical asses...
  • 83 Gender differences i...
  • 89 Reducing the dose of...
  • 90 Visual assessment of...
  • 100 Genetic polymorphism...
  • 103 Tackling inflammator...
  • 105 Vascular and myocard...
  • 107 Impaired elastic pro...
  • TDI is a better choi...
  • 116 Efficacy of I(f) inh...
  • 126 The FDA prasugrel re...
  • 130 Focusing on atrial r...
  • 132 Ventricular reverse ...
  • 142 Left-ventricular dia...
  • 150 Surgical treatment o...
  • 157 Noninvasive evaluati...
  • 164 Gender difference in...
  • 167 Cardiac troponin I d...
  • 174 G771C Polymorphism i...
  • 180 Enhanced activity of...
  • 192 Flushing profile of ...
  • 199 Arrhythmia susceptib...
  • 208 Infective endocardit...
  • 212 Role of the endocann...
  • 226 Left-ventricular pow...
  • 235 Ventricular septal d...
  • 238 A comparative study:...
  • 244 Noninvasive cardiac ...
  • 247 Noninvasive determin...
  • 255 Cardiac repolarizati...
  • 261 Urinary trypsin inhi...
  • 264 Urinary trypsin inhi...
  • Triple therapy can a...
  • 273 Heart rate variabili...
  • 275 Ultra-short-term hea...
  • 284 Major cerebral event...
  • 292 Prediction of hemody...
  • 298 Uric acid and cardio...
  • 300 Serum uric acid for ...

  Illustrations

  Choose Another Issue
• HTML Full Text